These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 23975373)
1. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk. Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373 [TBL] [Abstract][Full Text] [Related]
2. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer. Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038 [TBL] [Abstract][Full Text] [Related]
3. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer. Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275 [TBL] [Abstract][Full Text] [Related]
4. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma. Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697 [TBL] [Abstract][Full Text] [Related]
6. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer. Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577 [TBL] [Abstract][Full Text] [Related]
7. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis. Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923 [TBL] [Abstract][Full Text] [Related]
8. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD. Hu H; Zhang L; Teng G; Wu Y; Chen Y Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738 [TBL] [Abstract][Full Text] [Related]
9. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation. Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438 [TBL] [Abstract][Full Text] [Related]
10. Association of rs712 polymorphism in a let-7 microRNA-binding site of Gallegos-Arreola MP; Zúñiga-González GM; Gómez-Mariscal K; Rosales-Reynoso MA; Luis L; Puebla-Pérez AM; Pineda-Razo T Iran J Basic Med Sci; 2019 Mar; 22(3):324-327. PubMed ID: 31156795 [TBL] [Abstract][Full Text] [Related]
11. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis. Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C J BUON; 2015; 20(1):309-16. PubMed ID: 25778332 [TBL] [Abstract][Full Text] [Related]
12. rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population. Jiang QH; Peng HX; Zhang Y; Tian P; Xi ZL; Chen H Onco Targets Ther; 2015; 8():3041-5. PubMed ID: 26543374 [TBL] [Abstract][Full Text] [Related]
13. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival. Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830 [TBL] [Abstract][Full Text] [Related]
14. Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. Kjersem JB; Ikdahl T; Guren T; Skovlund E; Sorbye H; Hamfjord J; Pfeiffer P; Glimelius B; Kersten C; Solvang H; Tveit KM; Kure EH BMC Cancer; 2012 Nov; 12():534. PubMed ID: 23167843 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575 [TBL] [Abstract][Full Text] [Related]
17. A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study. Liang Y; Sun R; Li L; Yuan F; Liang W; Wang L; Nie X; Chen P; Zhang L; Gao L Medicine (Baltimore); 2015 Aug; 94(31):e1289. PubMed ID: 26252302 [TBL] [Abstract][Full Text] [Related]
18. TP53 and let-7a micro-RNA regulate K-Ras activity in HCT116 colorectal cancer cells. Luu C; Heinrich EL; Duldulao M; Arrington AK; Fakih M; Garcia-Aguilar J; Kim J PLoS One; 2013; 8(8):e70604. PubMed ID: 23936455 [TBL] [Abstract][Full Text] [Related]
19. KRAS polymorphisms are associated with survival of CRC in Chinese population. Dai Q; Wei HL; Huang J; Zhou TJ; Chai L; Yang ZH Tumour Biol; 2016 Apr; 37(4):4727-34. PubMed ID: 26515332 [TBL] [Abstract][Full Text] [Related]
20. Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Graziano F; Canestrari E; Loupakis F; Ruzzo A; Galluccio N; Santini D; Rocchi M; Vincenzi B; Salvatore L; Cremolini C; Spoto C; Catalano V; D'Emidio S; Giordani P; Tonini G; Falcone A; Magnani M Pharmacogenomics J; 2010 Oct; 10(5):458-64. PubMed ID: 20177422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]